Henrietta J. Ditzen

Henrietta’s experience includes advising:

• Acrotec (a portfolio company of The Carlyle Group) on the:
  • Acquisition of Friedrich Daniels
  • Acquisition of Mebus MIM-Technik
• A supplier of industrial solutions on the sale of a ceramics business
• Antin Infrastructure Partners on the acquisition of the majority stake in amedes Holding AG, a provider of medical diagnostic services
• Bregal Unternehmerkapital on the acquisition of medavis GmbH
• Cheplapharm on the:
  • Acquisition of the worldwide commercial rights (excluding South Korea) for Gemzar® from Eli Lilly and Company 
  • Acquisition of the worldwide commercial rights (excluding South Korea) for Zyprexa® from Eli Lilly and Company
  • Acquisition of the medicinal products Seroquel and Seroquel XR in Europe, Russia, the US, and Canada from AstraZeneca
• Demant on the:
  • Acquisition of OHRWERK Group
  • Agreement to acquire KIND Group
• DPE Deutsche Private Equity and Maxburg Capital Partners on the sale of PharmaZell GmbH
• EQT Partners AB on the acquisition of Siemens Audiology Solutions from Siemens
• Fresenius on the sale of the majority of Vamed’s rehabilitation business to PAI Partners
• Inari Medical on the acquisition of LimFlow
• ITM on the acquisition of a worldwide exclusive license for cancer treatment
• Juno Therapeutics on the acquisition of Stage Cell Therapeutics GmbH
• Medigo GmbH on corporate and regulatory advice in connection with establishing an online platform for medical tourism 
• Novo Nordisk on the acquisition of Cardior Pharmaceuticals
• Perrigo on its proposed divestiture of its dermacosmetics branded business
• Raptor Pharmaceuticals in connection with the product commercialization of an orphan drug in the EEA
• Siemens in connection with the internal reorganization of its healthcare division
• Tecan Trading AG on the acquisition of IBL International Holding B.V., a developer and distributor of in-vitro diagnostic test systems
• Thoratec Corporation on clinical trials in Germany and Austria
• Trilantic on the acquisition of the Deutsche Pflege und Wohnen Group and the Argentum Group in a combined purchase procedure
• TriVascular on medical device legislation and compliance 
• ZAVA Global on the sale to listed US-based Hims & Hers Health, Inc.